UBERON:0003929

Name:	gut epithelium
Namespace:	FANTOM
Definition:	"An epithelium that is part of a digestive tract [Obol]." [OBOL:automatic]
Xrefs:	Expandlinks: BTO:0000956 EHDAA2:0004567 ncithesaurus:Gut_Epithelium TAO:0005123 XAO:0003200 ZFA:0005123
Synonyms:	"digestive tract epithelial tissue" EXACT [OBOL:automatic] "digestive tract epithelium" EXACT [OBOL:automatic] "epithelial tissue of digestive tract" EXACT [OBOL:automatic] "epithelial tissue of gut" EXACT [OBOL:automatic] "epithelial tissue of lower gastrointestinal tract" EXACT [OBOL:automatic] "epithelium of digestive tract" EXACT [OBOL:automatic] "epithelium of gut" EXACT [OBOL:automatic] "epithelium of lower gastrointestinal tract" EXACT [OBOL:automatic] "gut epithelial tissue" EXACT [OBOL:automatic] "lower gastrointestinal tract epithelial tissue" EXACT [OBOL:automatic] "lower gastrointestinal tract epithelium" EXACT [OBOL:automatic]

Ontology association<br>Each term has an is_a parent in the Uberon Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to UBERON ontologies.<br><br>link to ontology dataset<br>data

---

Parents

is_a:	UBERON:0000483(epithelium)
part_of:	UBERON:0001555(digestive tract)

Children

is a:	UBERON:0001277 (intestinal epithelium),UBERON:0002424 (oral epithelium),UBERON:0003351 (pharyngeal epithelium),UBERON:0003353 (epithelium of hindgut),UBERON:0004809 (salivary gland epithelium),UBERON:0009497 (epithelium of foregut-midgut junction),UBERON:0012481 (cloacal epithelium),UBERON:0015833 (foregut epithelium)
part of:	CL:0000682 (M cell of gut),UBERON:0009497 (epithelium of foregut-midgut junction),UBERON:0009722 (entire pharyngeal arch endoderm),UBERON:0009846 (embryonic cloacal epithelium)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples<br>It includes FANTOM5 samples that overlay the Uberon ontology

---

Human (Homo sapiens)

• 10420-106C6 (colon carcinoma cell line:COLO-320)
• 10511-107D7
• 10513-107D9 (colon carcinoma cell line:CACO-2)
• 10523-107F1
• 10557-107I8
• 10635-108I5
• 10653-109B5
• 10812-111B2 (normal intestinal epithelial cell line:FHs 74 Int)
• 11221-116B6 (Gingival epithelial cells, donor1 (GEA11))
• 11246-116E4 (Intestinal epithelial cells (polarized), donor1)

... further results Mouse (Mus musculus)

• 10420-106C6 (colon carcinoma cell line:COLO-320)
• 10511-107D7
• 10513-107D9 (colon carcinoma cell line:CACO-2)
• 10523-107F1
• 10557-107I8
• 10635-108I5
• 10653-109B5
• 10812-111B2 (normal intestinal epithelial cell line:FHs 74 Int)
• 11221-116B6 (Gingival epithelial cells, donor1 (GEA11))
• 11246-116E4 (Intestinal epithelial cells (polarized), donor1)

... further results

Enrichment analysis: top 100 FFCP enriched with this ontology term TOP 100 FANTOM5 Cage Peaks enriched with UBERON:0003929 (gut epithelium), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

---

Copy Excel CSV PDF

Search:

P-value	FFCP	Short description

P-value	FFCP	Short description
8.73e-40	FFCP PHASE2:Hg19::chr6:8652489..8652515,+	p1@HULC
8.73e-40	FFCP PHASE1:Hg19::chr6:8652489..8652515,+	p1@HULC
1.57e-36	FFCP PHASE1:Hg19::chr10:101841398..101841415,-	p2@CPN1
1.57e-36	FFCP PHASE2:Hg19::chr10:101841398..101841415,-	p2@CPN1
1.73e-36	FFCP PHASE1:Hg19::chr10:101841588..101841632,-	p1@CPN1
1.73e-36	FFCP PHASE2:Hg19::chr10:101841588..101841632,-	p1@CPN1
2.65e-36	FFCP PHASE2:Mm9::chr14:30823509..30823529,+	p@chr14:30823509..30823529, +
2.65e-36	FFCP PHASE1:Mm9::chr14:30823509..30823529,+	p@chr14:30823509..30823529, +
3.89e-36	FFCP PHASE1:Hg19::chr6:64231600..64231615,+	p24@PTP4A1
3.89e-36	FFCP PHASE2:Hg19::chr6:64231600..64231615,+	p24@PTP4A1
5.11e-34	FFCP PHASE2:Hg19::chr12:100867777..100867788,+	p5@NR1H4
5.11e-34	FFCP PHASE1:Hg19::chr12:100867777..100867788,+	p5@NR1H4
4.28e-33	FFCP PHASE2:Hg19::chr1:161192171..161192185,-	p@chr1:161192171..161192185, -
4.28e-33	FFCP PHASE1:Hg19::chr1:161192171..161192185,-	p@chr1:161192171..161192185, -
1.09e-32	FFCP PHASE2:Hg19::chr20:10349456..10349475,-	p1@ENST00000421143
1.09e-32	FFCP PHASE1:Hg19::chr20:10349456..10349475,-	p1@ENST00000421143
7.4e-31	FFCP PHASE1:Hg19::chr17:7082668..7082725,-	p1@ASGR1
7.4e-31	FFCP PHASE2:Hg19::chr17:7082668..7082725,-	p1@ASGR1
9.27e-31	FFCP PHASE1:Hg19::chr1:161192149..161192162,-	p@chr1:161192149..161192162, -
9.27e-31	FFCP PHASE2:Hg19::chr1:161192149..161192162,-	p@chr1:161192149..161192162, -
9.81e-31	FFCP PHASE1:Hg19::chr1:54359854..54359866,+	p1@DIO1
9.81e-31	FFCP PHASE2:Hg19::chr1:54359854..54359866,+	p1@DIO1
1.52e-30	FFCP PHASE2:Hg19::chr1:177939154..177939204,-	p4@SEC16B
1.52e-30	FFCP PHASE1:Hg19::chr1:177939154..177939204,-	p4@SEC16B
1.82e-30	FFCP PHASE2:Hg19::chr22:37505474..37505478,-	p3@TMPRSS6
1.82e-30	FFCP PHASE1:Hg19::chr22:37505474..37505478,-	p3@TMPRSS6
6.95e-30	FFCP PHASE1:Hg19::chr17:7082560..7082572,-	p4@ASGR1
6.95e-30	FFCP PHASE2:Hg19::chr17:7082560..7082572,-	p4@ASGR1
8.03e-30	FFCP PHASE2:Hg19::chr19:56653064..56653103,+	p1@AK124209
8.03e-30	FFCP PHASE1:Hg19::chr19:56653064..56653103,+	p1@AK124209
8.91e-30	FFCP PHASE2:Hg19::chr4:155528001..155528060,-	p@chr4:155528001..155528060, -
8.91e-30	FFCP PHASE1:Hg19::chr4:155533277..155533357,-	p2@FGG
8.91e-30	FFCP PHASE1:Hg19::chr4:155528001..155528060,-	p@chr4:155528001..155528060, -
8.91e-30	FFCP PHASE2:Hg19::chr4:155533277..155533357,-	p2@FGG
8.91e-30	FFCP PHASE1:Hg19::chr1:161192118..161192141,-	p@chr1:161192118..161192141, -
8.91e-30	FFCP PHASE2:Hg19::chr4:155530853..155530879,-	p3@FGG
8.91e-30	FFCP PHASE1:Hg19::chr4:155530853..155530879,-	p3@FGG
8.91e-30	FFCP PHASE2:Hg19::chr1:161192118..161192141,-	p@chr1:161192118..161192141, -
1.01e-29	FFCP PHASE1:Hg19::chr11:63137251..63137267,+	p1@SLC22A9
1.01e-29	FFCP PHASE2:Hg19::chr11:63137251..63137267,+	p1@SLC22A9
1.04e-29	FFCP PHASE2:Hg19::chr17:7017634..7017649,-	p7@ASGR2
1.04e-29	FFCP PHASE1:Hg19::chr17:7017634..7017649,-	p7@ASGR2
1.19e-29	FFCP PHASE1:Hg19::chr14:94759595..94759613,-	p2@SERPINA10
1.19e-29	FFCP PHASE2:Hg19::chr14:94759595..94759613,-	p2@SERPINA10
1.32e-29	FFCP PHASE1:Hg19::chr14:94759576..94759594,-	p3@SERPINA10
1.32e-29	FFCP PHASE2:Hg19::chr14:94759576..94759594,-	p3@SERPINA10
2.94e-29	FFCP PHASE2:Hg19::chr16:85832119..85832145,+	p@chr16:85832119..85832145, +
2.94e-29	FFCP PHASE1:Hg19::chr16:85832119..85832145,+	p@chr16:85832119..85832145, +
3.04e-29	FFCP PHASE1:Hg19::chr8:144417558..144417572,-	p7@TOP1MT
3.04e-29	FFCP PHASE2:Hg19::chr8:144417558..144417572,-	p7@TOP1MT
3.04e-29	FFCP PHASE2:Hg19::chr2:21233797..21233804,-	p58@APOB
3.04e-29	FFCP PHASE1:Hg19::chr2:21233797..21233804,-	p58@APOB
2.05e-28	FFCP PHASE1:Hg19::chr4:70361615..70361631,-	p1@UGT2B4
2.05e-28	FFCP PHASE2:Hg19::chr4:70361615..70361631,-	p1@UGT2B4
2.17e-28	FFCP PHASE1:Hg19::chr12:24191262..24191291,-	p@chr12:24191262..24191291, -
2.17e-28	FFCP PHASE2:Hg19::chr12:24191262..24191291,-	p@chr12:24191262..24191291, -
2.82e-28	FFCP PHASE1:Hg19::chr17:7017968..7018021,-	p1@ASGR2
2.82e-28	FFCP PHASE2:Hg19::chr17:7017968..7018021,-	p1@ASGR2
6.93e-28	FFCP PHASE1:Hg19::chr14:94759548..94759571,-	p1@SERPINA10
6.93e-28	FFCP PHASE2:Hg19::chr14:94759548..94759571,-	p1@SERPINA10
7.03e-28	FFCP PHASE2:Hg19::chr12:100867695..100867706,+	p6@NR1H4
7.03e-28	FFCP PHASE1:Hg19::chr12:100867695..100867706,+	p6@NR1H4
8.24e-28	FFCP PHASE2:Hg19::chr13:113760134..113760150,+	p2@F7
8.24e-28	FFCP PHASE1:Hg19::chr13:113760134..113760150,+	p2@F7
1.62e-27	FFCP PHASE1:Hg19::chr6:64231645..64231678,+	p6@PTP4A1
1.62e-27	FFCP PHASE2:Hg19::chr6:64231645..64231678,+	p6@PTP4A1
1.87e-27	FFCP PHASE1:Hg19::chr2:201171064..201171071,+	p19@SPATS2L
1.87e-27	FFCP PHASE2:Hg19::chr2:201171064..201171071,+	p19@SPATS2L
2.04e-27	FFCP PHASE2:Hg19::chr17:4692335..4692344,+	p3@GLTPD2
2.04e-27	FFCP PHASE1:Hg19::chr17:4692335..4692344,+	p3@GLTPD2
2.4e-27	FFCP PHASE2:Mm9::chr11:60622345..60622377,-	p@chr11:60622345..60622377, -
2.4e-27	FFCP PHASE1:Mm9::chr11:60622345..60622377,-	p@chr11:60622345..60622377, -
2.64e-27	FFCP PHASE1:Hg19::chr4:74283297..74283332,-	p@chr4:74283297..74283332, -
2.64e-27	FFCP PHASE2:Hg19::chr4:74283297..74283332,-	p@chr4:74283297..74283332, -
5.31e-27	FFCP PHASE2:Mm9::chr5:90897694..90897705,+	p@chr5:90897694..90897705, +
5.31e-27	FFCP PHASE1:Mm9::chr5:90897694..90897705,+	p@chr5:90897694..90897705, +
5.91e-27	FFCP PHASE1:Mm9::chr8:131012371..131012382,-	p2@uc009nzu.1
5.91e-27	FFCP PHASE2:Mm9::chr6:41483037..41483046,+	p8@uc009bpa.1
5.91e-27	FFCP PHASE1:Mm9::chr6:41483037..41483046,+	p8@uc009bpa.1
5.91e-27	FFCP PHASE2:Mm9::chr8:131012371..131012382,-	p2@uc009nzu.1
6.71e-27	FFCP PHASE2:Mm9::chr19:25169885..25169900,+	p@chr19:25169885..25169900, +
6.71e-27	FFCP PHASE1:Mm9::chr19:25169885..25169900,+	p@chr19:25169885..25169900, +
6.76e-27	FFCP PHASE1:Mm9::chr6:41483113..41483131,+	p4@uc009bpa.1
6.76e-27	FFCP PHASE2:Mm9::chr6:41483113..41483131,+	p4@uc009bpa.1
7.17e-27	FFCP PHASE1:Mm9::chr7:121912281..121912295,+	p6@Insc
7.17e-27	FFCP PHASE2:Mm9::chr7:121912281..121912295,+	p6@Insc
7.25e-27	FFCP PHASE1:Hg19::chr22:50826072..50826087,+	p@chr22:50826072..50826087, +
7.25e-27	FFCP PHASE2:Hg19::chr22:50826072..50826087,+	p@chr22:50826072..50826087, +
1.11e-26	FFCP PHASE2:Hg19::chr8:17752845..17752864,-	p2@FGL1
1.11e-26	FFCP PHASE1:Hg19::chr8:17752845..17752864,-	p2@FGL1
1.47e-26	FFCP PHASE2:Hg19::chr10:54531372..54531384,-	p1@MBL2
1.47e-26	FFCP PHASE1:Hg19::chr10:54531372..54531384,-	p1@MBL2
1.5e-26	FFCP PHASE2:Hg19::chr11:116706961..116706976,-	p@chr11:116706961..116706976, -
1.5e-26	FFCP PHASE1:Hg19::chr11:116706961..116706976,-	p@chr11:116706961..116706976, -
1.57e-26	FFCP PHASE2:Hg19::chr17:7082573..7082598,-	p5@ASGR1
1.57e-26	FFCP PHASE1:Hg19::chrX:153769426..153769436,+	p18@IKBKG
1.57e-26	FFCP PHASE1:Hg19::chr17:7082573..7082598,-	p5@ASGR1
1.57e-26	FFCP PHASE2:Hg19::chrX:153769426..153769436,+	p18@IKBKG
1.77e-26	FFCP PHASE1:Hg19::chr4:155527893..155527907,-	p@chr4:155527893..155527907, -
1.77e-26	FFCP PHASE2:Hg19::chr4:155527893..155527907,-	p@chr4:155527893..155527907, -

Showing 1 to 100 of 100 entries

Property "Property value" (as page type) with input value "UBPROP:0000001 "Epithelium lining the lumen of the gut.[TAO]" xsd:string" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.